Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) EBIT Margin (2021 - 2026)

Core Scientific has reported EBIT Margin over the past 6 years, most recently at 269.36% for Q1 2026.

  • Quarterly results put EBIT Margin at 269.36% for Q1 2026, down 21021.0% from a year ago — trailing twelve months through Mar 2026 was 143.48% (down 8402.0% YoY), and the annual figure for FY2025 was 76.98%, down 4916.0%.
  • EBIT Margin reached 269.36% in Q1 2026 per CORZ's latest filing, down from 147.28% in the prior quarter.
  • Across five years, EBIT Margin topped out at 30.8% in Q1 2024 and bottomed at 637.54% in Q2 2022.
  • Median EBIT Margin over the past 5 years was 59.15% (2025), compared with a mean of 125.85%.
  • The largest annual shift saw EBIT Margin plummeted -65816bps in 2022 before it skyrocketed 64500bps in 2023.
  • Over 5 years, EBIT Margin stood at 524.6% in 2022, then soared by 101bps to 2.77% in 2023, then plummeted by -2585bps to 68.89% in 2024, then crashed by -114bps to 147.28% in 2025, then plummeted by -83bps to 269.36% in 2026.
  • Business Quant data shows EBIT Margin for CORZ at 269.36% in Q1 2026, 147.28% in Q4 2025, and 67.56% in Q3 2025.